Featured image for “Ten Years of Pembrolizumab Shows Sustained Results”
09/15/2024

Ten Years of Pembrolizumab Shows Sustained Results

There is good news for patients with advanced melanoma who received pembrolizumab. Results from a clinical trial after ten years…
Blog - Melanoma360
Melanoma Research
Featured image for “Fall 2024 Newsletter”
10/10/2024

Fall 2024 Newsletter

…committee Thank you for your continued support in advancing melanoma research. Together, we can make a difference in the fight…
Blog - Melanoma360
President's Letter
07/27/2015

Sunscreen

…of sunscreen was clearly demonstrated in a large Australian randomized trial published in 2010, which showed a 50% decreased melanoma…
02/17/2019

Our Industry Partners

Discovering the Cure for Melanoma, Together Our goal is to align with corporate partners that share our commitment to finding…
04/30/2019

Connecticut

…of Medicine 333 Cedar Street New Haven, CT 06520 203-200-6622 yalecancercenter.org Deepak Narayan, MD, Clinical Program Leader, Melanoma Program Mario…
05/10/2020

Planned Giving

Your legacy can fund melanoma research. Leaving a gift to AIM as part of your estate is a wonderful way…
09/17/2020

Lurie Cancer Center | November 12

…Do I Need Therapy for My Stage II or Stage III Melanoma? Jeffrey Wayne, MD, FACS 5:55 PM What are…
04/18/2022

Taking Care of You, The Caregiver

…one with melanoma meet his/her needs. And yet, what about you? We will now discuss your needs as the caregiver and strategies…
01/16/2024

UPMC Hillman Cancer Center | March 16, 2024

This virtual and in-person symposium is presented by AIM at Melanoma and UPMC Hillman Cancer Center held at UPMC Hillman…
07/03/2024

Our Industry Partners v2

About AIM\n\n Our Mission\n\n Our Industry Partners\n\n Our Corporate and Non-Profit Partners\n\n Our Global Influence\n\n Blog – Melanoma360\n\n Newsletters &…

Ten Years of Pembrolizumab Shows Sustained Results

There is good news for patients with advanced melanoma who received pembrolizumab. Results from a clinical trial after ten years…
Featured image for “Ten Years of Pembrolizumab Shows Sustained Results”
Blog - Melanoma360
Melanoma Research

Fall 2024 Newsletter

…committee Thank you for your continued support in advancing melanoma research. Together, we can make a difference in the fight…
Featured image for “Fall 2024 Newsletter”
Blog - Melanoma360
President's Letter

Sunscreen

…of sunscreen was clearly demonstrated in a large Australian randomized trial published in 2010, which showed a 50% decreased melanoma…
Featured image for “Sunscreen”

Our Industry Partners

Discovering the Cure for Melanoma, Together Our goal is to align with corporate partners that share our commitment to finding…
Featured image for “Our Industry Partners”

Connecticut

…of Medicine 333 Cedar Street New Haven, CT 06520 203-200-6622 yalecancercenter.org Deepak Narayan, MD, Clinical Program Leader, Melanoma Program Mario…
Featured image for “Connecticut”

Planned Giving

Your legacy can fund melanoma research. Leaving a gift to AIM as part of your estate is a wonderful way…
Featured image for “Planned Giving”

Lurie Cancer Center | November 12

…Do I Need Therapy for My Stage II or Stage III Melanoma? Jeffrey Wayne, MD, FACS 5:55 PM What are…
Featured image for “Lurie Cancer Center | November 12”

Taking Care of You, The Caregiver

…one with melanoma meet his/her needs. And yet, what about you? We will now discuss your needs as the caregiver and strategies…
Featured image for “Taking Care of You, The Caregiver”

UPMC Hillman Cancer Center | March 16, 2024

This virtual and in-person symposium is presented by AIM at Melanoma and UPMC Hillman Cancer Center held at UPMC Hillman…
Featured image for “UPMC Hillman Cancer Center  | March 16, 2024”

Our Industry Partners v2

About AIM\n\n Our Mission\n\n Our Industry Partners\n\n Our Corporate and Non-Profit Partners\n\n Our Global Influence\n\n Blog – Melanoma360\n\n Newsletters &…
Featured image for “Our Industry Partners v2”